Harsh Singh is an executive leader with extensive experience in R&D strategy, portfolio management, and operations in the pharmaceutical and biotech industries. Currently serving as Chief of Staff and Head of Portfolio Governance Management at Roche, they oversee global gene therapy development and manage significant development budgets. Previously, Harsh directed strategic partnerships and business operations at Roche, led global biomarker operations for oncology, and held various leadership roles at Celerion and Eurofins. With a strong focus on driving innovation and organizational transformation, Harsh has consistently optimized operations and contributed to numerous high-impact studies throughout their career.
This person is not in any teams
This person is not in any offices